Cargando…

High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients

BACKGROUND: Migraine is a common headache disorder that may be associated with vascular disease and cerebral white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) scan. High sensitivity C-reactive protein (hs-CRP) is a marker of inflammation that may predict subclinical atheroscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Avci, Aynur Yilmaz, Lakadamyali, Hatice, Arikan, Serap, Benli, Ulku Sibel, Kilinc, Munire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417106/
https://www.ncbi.nlm.nih.gov/pubmed/25595197
http://dx.doi.org/10.1186/1129-2377-16-9
_version_ 1782369306203389952
author Avci, Aynur Yilmaz
Lakadamyali, Hatice
Arikan, Serap
Benli, Ulku Sibel
Kilinc, Munire
author_facet Avci, Aynur Yilmaz
Lakadamyali, Hatice
Arikan, Serap
Benli, Ulku Sibel
Kilinc, Munire
author_sort Avci, Aynur Yilmaz
collection PubMed
description BACKGROUND: Migraine is a common headache disorder that may be associated with vascular disease and cerebral white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) scan. High sensitivity C-reactive protein (hs-CRP) is a marker of inflammation that may predict subclinical atherosclerosis. However, the relation between migraine, vascular risks, and WMHs is unknown. We evaluated hs-CRP levels and the relation between hs-CRP level and WMHs in adult migraine patients. METHODS: This case–control study included 432 subjects (216 migraine patients [without aura, 143 patients; with aura, 73 patients]; 216 healthy control subjects without migraine; age range 18–50 y). Migraine diagnosis was determined according to the International Classification of Headache Disorders II diagnostic criteria. The migraine patients and control subjects had no known vascular risk factors, inflammatory disease, or comorbid disease. The presence and number of WMHs on MRI scans were determined, and serum hs-CRP levels were measured by latex-enhanced immunoturbidimetry. RESULTS: Mean hs-CRP level was significantly greater in migraine patients (1.94 ± 2.03 mg/L) than control subjects (0.82 ± 0.58 mg/L; P ≤ .0001). The mean number of WMHs per subject and the presence of WMHs was significantly greater in migraine patients (69 patients [31.9%]; 1.68 ± 3.12 mg/dL) than control subjects (21 subjects [9.7%]; 0.3 ± 1.3; P ≤ .001). However, there was no correlation between hs-CRP level and WMHs in migraine patients (r = 0.024; not significant). The presence of WMHs was increased 4.35-fold in migraine patients (odds ratio 4.35, P ≤ .001). CONCLUSIONS: High hs-CRP level may be a marker of the proinflammatory state in migraine patients. However, the absence of correlation between hs-CRP level and WMHs suggests that hs-CRP is not causally involved in the pathogenesis of WMHs in migraine patients. The WMHs were located mostly in the frontal lobe and subcortical area.
format Online
Article
Text
id pubmed-4417106
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-44171062015-05-14 High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients Avci, Aynur Yilmaz Lakadamyali, Hatice Arikan, Serap Benli, Ulku Sibel Kilinc, Munire J Headache Pain Research Article BACKGROUND: Migraine is a common headache disorder that may be associated with vascular disease and cerebral white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) scan. High sensitivity C-reactive protein (hs-CRP) is a marker of inflammation that may predict subclinical atherosclerosis. However, the relation between migraine, vascular risks, and WMHs is unknown. We evaluated hs-CRP levels and the relation between hs-CRP level and WMHs in adult migraine patients. METHODS: This case–control study included 432 subjects (216 migraine patients [without aura, 143 patients; with aura, 73 patients]; 216 healthy control subjects without migraine; age range 18–50 y). Migraine diagnosis was determined according to the International Classification of Headache Disorders II diagnostic criteria. The migraine patients and control subjects had no known vascular risk factors, inflammatory disease, or comorbid disease. The presence and number of WMHs on MRI scans were determined, and serum hs-CRP levels were measured by latex-enhanced immunoturbidimetry. RESULTS: Mean hs-CRP level was significantly greater in migraine patients (1.94 ± 2.03 mg/L) than control subjects (0.82 ± 0.58 mg/L; P ≤ .0001). The mean number of WMHs per subject and the presence of WMHs was significantly greater in migraine patients (69 patients [31.9%]; 1.68 ± 3.12 mg/dL) than control subjects (21 subjects [9.7%]; 0.3 ± 1.3; P ≤ .001). However, there was no correlation between hs-CRP level and WMHs in migraine patients (r = 0.024; not significant). The presence of WMHs was increased 4.35-fold in migraine patients (odds ratio 4.35, P ≤ .001). CONCLUSIONS: High hs-CRP level may be a marker of the proinflammatory state in migraine patients. However, the absence of correlation between hs-CRP level and WMHs suggests that hs-CRP is not causally involved in the pathogenesis of WMHs in migraine patients. The WMHs were located mostly in the frontal lobe and subcortical area. Springer Milan 2015-01-16 /pmc/articles/PMC4417106/ /pubmed/25595197 http://dx.doi.org/10.1186/1129-2377-16-9 Text en © Avci et al.; licensee Springer. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Avci, Aynur Yilmaz
Lakadamyali, Hatice
Arikan, Serap
Benli, Ulku Sibel
Kilinc, Munire
High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title_full High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title_fullStr High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title_full_unstemmed High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title_short High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
title_sort high sensitivity c-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417106/
https://www.ncbi.nlm.nih.gov/pubmed/25595197
http://dx.doi.org/10.1186/1129-2377-16-9
work_keys_str_mv AT avciaynuryilmaz highsensitivitycreactiveproteinandcerebralwhitematterhyperintensitiesonmagneticresonanceimaginginmigrainepatients
AT lakadamyalihatice highsensitivitycreactiveproteinandcerebralwhitematterhyperintensitiesonmagneticresonanceimaginginmigrainepatients
AT arikanserap highsensitivitycreactiveproteinandcerebralwhitematterhyperintensitiesonmagneticresonanceimaginginmigrainepatients
AT benliulkusibel highsensitivitycreactiveproteinandcerebralwhitematterhyperintensitiesonmagneticresonanceimaginginmigrainepatients
AT kilincmunire highsensitivitycreactiveproteinandcerebralwhitematterhyperintensitiesonmagneticresonanceimaginginmigrainepatients